Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686348 · ClinicalTrials.gov registry record
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 260
- Enrollment target
NCT00686348: Completed study, sponsored by Ipsen.
NCT00686348 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686348 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
To assess the safety and effectiveness of Somatuline® Depot (lanreotide) Injection when administered by a health care professional (HCP), the patient, the patient's partner or parent/guardian as part of their routine acromegaly care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2008-05 |
| Est. Completion | 2015-11 |
What the finished NCT00686348 record still lists
NCT00686348 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00686348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00686348 about?
NCT00686348 is a clinical study titled "Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study". To assess the safety and effectiveness of Somatuline® Depot (lanreotide) Injection when administered by a health care professional (HCP), the patient, the patient's partner or parent/guardian as part of their routine acromegaly care.
What is the current status of trial NCT00686348?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2008-05. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT00686348?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia